Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand-induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+-nuclear fact

Safety of bisphosphonates

(2011) Michael Pazianas et al.   BONE

Unraveling estrogen action in osteoporosis

(2011) Susan A. Krum et al.   CELL CYCLE

Implication of the calcium sensing receptor and the Phosphoinositide 3-kinase/Akt pathway in the extracellular calcium-mediated migration of RAW 264.7 osteoclast precursor cells

(2010) Cédric Boudot et al.   BONE

c-Src-mediated Phosphorylation of Thyroid Hormone Receptor-interacting Protein 6 (TRIP6) Promotes Osteoclast Sealing Zone Formation

(2010) Brooke K. McMichael et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways

(2010) Chenghai Li et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-κB signaling pathway in colon cancer cells

(2010) Zhengfeng Yang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Synthesis and Biological Evaluation of Caffeic Acid 3,4-Dihydroxyphenethyl Ester

(2010) Zhizhen Zhang et al.   JOURNAL OF NATURAL PRODUCTS

Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathway

(2010) Chenghai Li et al.   Molecular Cancer

CADPE Inhibits PMA-Stimulated Gastric Carcinoma Cell Invasion and Matrix Metalloproteinase-9 Expression by FAK/MEK/ERK-Mediated AP-1 Activation

(2010) H. Han et al.   MOLECULAR CANCER RESEARCH

TREM2- and DAP12-Dependent Activation of PI3K Requires DAP10 and Is Inhibited by SHIP1

(2010) Q. Peng et al.   Science Signaling

RANK/RANKL: Regulators of Immune Responses and Bone Physiology

(2009) Andreas Leibbrandt et al.   Annals of the New York Academy of Sciences

Regulation of bone formation and remodeling by G-protein-coupled receptor 48

(2009) J. Luo et al.   DEVELOPMENT

Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation

(2009) Takako Negishi-Koga et al.   IMMUNOLOGICAL REVIEWS

Diphenylhydantoin Inhibits Osteoclast Differentiation and Function Through Suppression of NFATc1 Signaling

(2009) Masanori Koide et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Pulmonary Toxicity and Metabolic Activation of Dauricine in CD-1 Mice

(2009) H. Jin et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: A key mechanism in osteoporosis

(2008) Patrizia D'Amelio et al.   BONE

Cathepsin K Activity-dependent Regulation of Osteoclast Actin Ring Formation and Bone Resorption

(2008) Susan R. Wilson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The p85  Subunit of Class IA Phosphatidylinositol 3-Kinase Regulates the Expression of Multiple Genes Involved in Osteoclast Maturation and Migration

(2008) V. Munugalavadla et al.   MOLECULAR AND CELLULAR BIOLOGY

Osteoblasts induce Ca2+ oscillation-independent NFATc1 activation during osteoclastogenesis

(2008) Y. Kuroda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss

(2008) L. Sun et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Structure and estrogenic activity of new lignans from Iryanthera lancifolia

(2007) Dulce Mesa-Siverio et al.   BIOORGANIC & MEDICINAL CHEMISTRY